AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Biohit Oyj

Director's Dealing Jun 3, 2019

3304_dirs_2019-06-03_17441dcc-8fbe-4594-9b85-2cd5e3681679.html

Director's Dealing

Open in Viewer

Opens in native device viewer

Disclosure 372510

Biohit Oyj - Managers' transactions

Biohit Plc - Managers' transactions - Söderström

Person subject to the notification requirement

Name: Söderström, Daniela

Position: Other senior manager

Issuer: Biohit Plc

LEI: 74370089ATTSNBXJVT29

Notification type: INITIAL NOTIFICATION

Reference number: 74370089ATTSNBXJVT29_20190603065401_4

Transaction date: 2019-05-29

Instrument type: SHARE

ISIN: FI0009005482

Nature of the transaction: SUBSCRIPTION

(X) Linked to stock option programme

Transaction details

(1): Volume: 25 000 Unit price: 2.2766 EUR

Aggregated transactions

(1): Volume: 25 000 Volume weighted average price: 2.2766 EUR

Biohit Oyj

Semi Korpela

CEO

For additional information:

CEO Semi Korpela,

Biohit Oyj

tel +358 9 773 861

[email protected]

www.biohithealthcare.com

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com

Talk to a Data Expert

Have a question? We'll get back to you promptly.